Rocic, Petra <br/><br/>
Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Jun 2007 
 - H2729-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0363-6135 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.01330.2006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetophenones--pharmacology<br/>Animals<br/>Blood Flow Velocity<br/>Cells, Cultured<br/>Collateral Circulation--drug effects<br/>Coronary Circulation--drug effects<br/>Coronary Vessels--surgery<br/>Disease Models, Animal<br/>Ditiocarb--pharmacology<br/>Endothelial Cells--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Imidazoles--pharmacology<br/>Ligation<br/>MAP Kinase Signaling System--drug effects<br/>Male<br/>Myocardial Reperfusion Injury--enzymology<br/>NADPH Oxidases--antagonists & inhibitors<br/>Neovascularization, Physiologic<br/>Onium Compounds--pharmacology<br/>Oxygenases--antagonists & inhibitors<br/>Pyridines--pharmacology<br/>Rats<br/>Rats, Inbred WKY<br/>Reactive Oxygen Species--metabolism<br/>Superoxide Dismutase--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor A--metabolism<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors